Lexington, KY, United States of America

John Alan Main


Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 353(Granted Patents)


Company Filing History:


Years Active: 2001-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: John Alan Main: Innovator in Intranasal Drug Delivery

Introduction

John Alan Main is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of pharmaceutical technology, particularly in the development of drug delivery systems. With a total of 4 patents to his name, Main's work focuses on enhancing the self-administration of medications.

Latest Patents

One of Main's latest patents is a programmable multi-dose intranasal drug delivery device. This innovative apparatus allows for the self-administration of multiple doses of an intranasal liquid pharmaceutical composition, including opioid analgesics. The device features a drug delivery system containing several sealed vials, each holding a predetermined volume of the pharmaceutical composition. It includes a pump assembly that conveys the liquid from the vial and discharges it as a nasal spray upon manual activation by the patient. Additionally, the device is equipped with programmable means to sequentially advance a vial to the ready position after a prescribed time interval following the last activation.

Career Highlights

Throughout his career, John Alan Main has worked with esteemed organizations such as the University of Kentucky Research Foundation and Sandia National Laboratories. His experience in these institutions has allowed him to refine his skills and contribute to groundbreaking innovations in drug delivery systems.

Collaborations

Main has collaborated with notable colleagues, including Daniel Wermeling and Ryan Vallance. Their combined expertise has further advanced the development of effective drug delivery technologies.

Conclusion

John Alan Main's contributions to the field of intranasal drug delivery highlight his innovative spirit and dedication to improving patient care. His patents and collaborations reflect a commitment to advancing pharmaceutical technology for better health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…